<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antithrombotic xinmaining were composed with Moschus, Calculus Bovis, <z:chebi fb="0" ids="28093">Borneol</z:chebi>, Radix Ligusticum, Flos Sophorae Immaturus, Radix Salviae Miltiorrhizae, Leech, etc </plain></SENT>
<SENT sid="1" pm="."><plain>This preparation was suitable for treating channels and collaterals type of <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The dosage was 2-4 capsules (0.5 g/capsule) oral administration twice per day, 3-4 weeks as a therapeutic course </plain></SENT>
<SENT sid="3" pm="."><plain>The authors studied 158 cases of these patients compared with 117 cases of control group with <z:chebi fb="0" ids="52071">dextran</z:chebi> and Vinorutone </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical result showed that the obvious effective rate in the therapeutic group was 62.1% and the total effective rate 96.3%; the values in the control group were 38.5% and 86.3% respectively (P less than 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>The laboratory results showed that the blood viscosity, serum viscosity, hematocrit (vol %), RBC electrophoresis rate (micron/<z:chebi fb="63" ids="30000">sec</z:chebi>/v/cm) and platelet aggregation rate (%) before antithrombotic xinmaining administration were 5.82 +/- 0.82, 1.82 +/- 0.02, 52.81 +/- 6.70, 0.82 +/- 0.19 and 28.33 +/- 12.02 respectively; and those after the treatment were 4.72 +/- 0.65, 1.70 +/- 0.02, 48.76 +/- 0.40, 0.97 +/- 0.17 and 23.05 +/- 10.01 (mean +/- S), P less than 0.01 </plain></SENT>
<SENT sid="6" pm="."><plain>The toxicological study proved that the preparation was safe, no significant side-effect and good for <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> medication </plain></SENT>
</text></document>